Michelson Diagnostics VivoSight(TM) OCT Scanner Receives FDA 510(k) Clearance
January 12, 2010 14:00 ET | Michelson Diagnostics
ORPINGTON, United Kingdom, Jan. 12, 2010 (GLOBE NEWSWIRE) -- Michelson Diagnostics Ltd, the London, UK based developer and manufacturer of Optical Coherence Tomography (OCT) products, announced today...
Electro-Optical Sciences Appoints Charles Stiefel to Board of Directors
January 11, 2010 08:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - January 11, 2010) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced the appointment of Charles Stiefel to its Board of Directors. Mr. Stiefel...
Michelson Diagnostics Receives New Funding to Accelerate Growth
January 05, 2010 14:04 ET | Michelson Diagnostics
ORPINGTON, United Kingdom, Jan. 5, 2010 (GLOBE NEWSWIRE) -- Michelson Diagnostics Ltd, the London, UK based developer and manufacturer of Optical Coherence Tomography (OCT) products, has raised...
Michelson Diagnostics Awarded CE-Mark for Clinical Use of Its VivoSight OCT Scanner in Europe and for Non-Clinical Applications Worldwide
September 17, 2009 14:00 ET | Michelson Diagnostics
ORPINGTON, England, Sept. 17, 2009 (GLOBE NEWSWIRE) -- Michelson Diagnostics has announced the award of a CE-mark for its new VivoSight Optical Coherence Tomography (OCT) scanner, confirming its...
FDA Accepts Electro-Optical Sciences' MelaFind(R) Pre-Market Approval (PMA) Application for Review
August 04, 2009 07:37 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - August 4, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) announced today that the U.S. Food and Drug Administration (FDA) formally accepted for filing the...
Electro-Optical Sciences Appoints Anne Egger to Board of Directors
June 10, 2009 07:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - June 10, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced that it has appointed Anne Egger to its Board of Directors. Ms. Egger brings more...
Electro-Optical Sciences Submits MelaFind(R) Pre-Market Approval Application to FDA
June 04, 2009 07:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - June 4, 2009) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA) today announced the submission to the United States Food and Drug Administration (FDA) of its...
May Is Melanoma/Skin Cancer Detection and Prevention Month(R)
May 04, 2009 16:37 ET | AAD
SCHAUMBURG, IL--(Marketwire - May 4, 2009) - In recognition of Melanoma/Skin Cancer Detection and Prevention Month®, the American Academy of Dermatology (Academy) releases skin cancer news and...
Electro-Optical Sciences to Commemorate Melanoma Monday at NASDAQ Stock Market
April 30, 2009 16:01 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - April 30, 2009) - Electro-Optical Sciences (NASDAQ: MELA) today announced that the company will ring the NASDAQ Stock Market Opening Bell on Monday, May 4, 2009 at 9:30...
Electro-Optical Sciences Announces Additional Data From MelaFind(R) Pivotal Study Presented at American Academy of Dermatology Meeting
March 12, 2009 07:30 ET | Electro-Optical Sciences, Inc.
IRVINGTON, NY--(Marketwire - March 12, 2009) - Electro-Optical Sciences, Inc. (EOS) (NASDAQ: MELA) today announced that additional data on MelaFind®, the company's non-invasive, point-of-care...